Cancer RSS

Latest Cancer News & Press Releases

  • AbboMax Introduces Antibody Panels for Bcell and Tcell Lymphoma
  • AbboMax has developed the panels of antibodies to study lymphoma. Lymphoma is a malignant transformation of either B or T cells or their subtypes. The B-cell lymphomas are types of lymphoma affecting B cells. T-cell lymphomas are lymphomas that affect T cells. AbboMax, Inc. has been developing & manufacturing immunoassay reagents for many years in California.
  • By Abbomax, Inc - August 01, 2019
  • International conference on cancer science and robotics
  • Conference Series llc LTD Group welcomes you to attend the “International conference on Cancer Science & Robotics” which is going to be held during November 14-15, 2018 at Melbourne, Australia. The Cancer Science and Robotics 2018 will be a 2 days Event which will includes Keynote Speeches, Academic Session Speakers, Poster Presentation, Workshop, Young Research forum, Exhibition etc.
  • By Conference Series Llc Ltd - May 01, 2018
  • Ruspharmtech got a US patent for Alofanib
  • Company “Russian Pharmaceutical Technologies” (Ruspharmtech) has increased the commercial value of its patent profile by receiving an American patent. The document contains information about originality and innovativeness of company’s development - the drug alofanib, which is the first of class allosteric inhibitor of fibroblast growth factor receptor type 2 (FGFR2) intended for cancer treatment.
  • By Ruspharmtech - March 28, 2018